Furthermore, follow-up BMD is the factor most strongly predictive of fracture risk in men and women, new findings from Norway reveal. Whether rate of bone loss constitutes an independent risk ...

OBODENCE™ and XBRYK™ recommended for approval by the European Medicines Agency for all indications referencing Prolia and Xgeva, respectivelyINCHEON, South Korea, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Co ...

Many men remain unaware of their osteoporosis status ... such as glucocorticoids (used to treat asthma or rheumatoid ...

Bone loss for men occurs much more gradually. However, by age 75, osteoporosis is as common in men as it is in women. To help ...

Despite being known as an ‘old women’s disease’, osteoporosis poses a significant threat to men’s health, with one in five at risk of fractures.

And so far, these drugs, the oldest of which is Fosomax, which was approved in 1995, seem to be remarkably well tolerated and very safe at bone in the overwhelming majority of people who take them.